Sign inJoin waitlistJoin the waitlist

Carrie Ho

Chief Resident, Internal Medicine

Credentials: · · ·

History

Internal Medicine
University of California (San Francisco) School of Medicine
Chief Resident2026–Present
2023–2026
Hematology and Medical Oncology
University of Washington-Seattle Campus
2021–2024
Hospital of the University of Pennsylvania
2017–2020
Ohio State University College of Medicine
2013–2017
Duke University
2008–2012

Research

Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk
Proceedings of the National Academy of Sciences of the United States of America · 2013 · 69 citations
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
Journal of Clinical Oncology · 2024 · 44 citations
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
Blood · 2025 · 33 citations

Mazyar Shadman
7 papers
Stephen Smith
7 papers
Aditi Saha
4 papers · 4 as a fellow
Ajay Gopal
4 papers
Ryan Lynch
4 papers
Sallie Permar
4 papers
Adam Kittai
3 papers
Brian Till
3 papers
Chaitra Ujjani
3 papers
CP
Christina Poh
3 papers
David Bond
3 papers
Deborah Stephens
3 papers

Clinical trials

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma
Principal investigator · Not yet recruiting · Phase 2
Carrie Ho, MD
2026–2029
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Principal investigator · Recruiting · Phase 1
C. Babis Andreadis
2020–2026